Overseas, Asian shares were trading higher. US stocks rallied on Friday, 23 February 2018, to end a bumpy week with slight gains, as falling bond yields provided a reprieve for investors concerned about rising inflation.
Back home, Dr Reddy's Laboratories was down 2.50%. The company said that United States Food & Drug Administration (USFDA) has maintained official action indicated (OAI) status of company's active pharmaceutical ingredient (API) manufacturing plant at Srikakulam, Andhra Pradesh after the audit. The company has received the establishment inspection report to that effect. The USFDA has asked the company for more details. The company is providing those details and continuing to engage with USFDA for resolution of pending issues. The announcement was made on Sunday, 25 February 2018.
Axis Bank was up 0.83%. With regard to media report titled "Axis Bank asks CIO Amit Sethi to Resign", the bank issued a clarification on Friday, 23 February 2018. Axis Bank said that in terms of its code of conduct and ethics, certain related matters are being subjected to internal investigation and in view of the same, it is unable to offer any comments in the matter.
Further, the said internal investigation is being conducted in the ordinary course of the business of the bank and is not material to the operations of the bank, Axis Bank said. The clarification was issued after market hours on Friday, 23 February 2018.
Idea Cellular was up 1.22%. The company announced the successful closure of its qualified institutions placement (QIP). The company has allotted 42.42 crore equity shares to qualified institutional buyers (QIBs), at an issue price of Rs 82.50 per share, aggregating to Rs 3500 crore. The announcement was made after market hours on Friday, 23 February 2018.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.